ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,905.20
      -0.91%
      Dow Jones
      38,460.92
      0.00%
      Brent Oil
      87.385
      0.19%
      Bitcoin
      63,773.67
      -0.79%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Viracta Therapeutics Inc (VIRX)

      7. Viracta Therapeutics Inc (VIRX) News

      VIRX Viracta Therapeutics Inc

      0.8363
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:48:17
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Viracta Therapeutics Inc VIRX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 0.8363 07:48:17
      Open Price Low Price High Price Close Price Prev Close
      0.8363
      more quote information »

      Recent News

      Date Time Source Heading
      4/15/202408:00GLOBEViracta Therapeutics Announces Positive Topline Nana-val..
      4/01/202408:30GLOBEViracta Therapeutics to Present Topline Nana-val Results..
      3/07/202417:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
      3/07/202416:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      3/07/202416:12EDGAR2Form 8-K - Current report
      3/07/202416:05GLOBEViracta Therapeutics Reports Fourth Quarter and Full Year..
      2/29/202408:00GLOBEViracta Therapeutics Announces Completion of Second-Stage..
      2/27/202420:40EDGAR2Form 144 - Report of proposed sale of securities
      2/27/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/27/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202421:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/06/202416:05GLOBEViracta Therapeutics to Present at the Oppenheimer 34th..
      1/04/202408:00GLOBEViracta Therapeutics Provides Clinical Update and Outlook..
      12/12/202308:00GLOBEViracta Therapeutics Announces Orphan Drug Designation..
      12/04/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/04/202308:30GLOBEViracta Therapeutics Announces Interim Data from Phase 1b/2..
      11/28/202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/28/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/17/202317:30EDGAR2Form 8-K - Current report
      11/09/202316:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/09/202308:30EDGAR2Form 8-K - Current report
      11/09/202308:30GLOBEViracta Therapeutics Reports Third Quarter 2023 Financial..
      11/07/202316:15GLOBEViracta Therapeutics to Present at Upcoming Investor..
      10/04/202307:01EDGAR2Form 8-K - Current report
      10/04/202307:00GLOBEViracta Therapeutics to Host R&D Day Highlighting Nana-val..
      9/05/202309:00GLOBEViracta Therapeutics to Host R&D Day on October 4, 2023
      8/29/202318:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/29/202318:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/18/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/18/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/18/202316:05GLOBEViracta Therapeutics Announces New Employment Inducement..
      8/16/202317:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
      8/14/202316:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/14/202308:02EDGAR2Form 8-K - Current report
      8/14/202308:00GLOBEViracta Therapeutics Reports Second Quarter 2023 Financial..
      8/08/202308:30GLOBEViracta Therapeutics Announces Publication in Blood Advances..
      8/07/202307:36EDGAR2Form 8-K - Current report
      8/07/202307:30GLOBEViracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D...
      6/28/202308:00GLOBEViracta Therapeutics’ Pivotal NAVAL-1 Trial Achieves..
      5/31/202316:15GLOBEViracta Therapeutics to Present at the Jefferies Healthcare..
      5/11/202316:05GLOBEViracta Therapeutics to Present at the RBC Capital Markets..
      5/08/202316:05GLOBEViracta Therapeutics Reports First Quarter 2023 Financial..
      5/02/202316:05GLOBEViracta Therapeutics Announces Departure of Chief Medical..

      Your Recent History

      NASDAQ
      VIRX
      Viracta Therapeutics
      Delayed Upgrade Clock